Based on intensity signal comparison, B55α expression is low or negative in 12 of 18 of prostate tumor cores (~67%) (Fig. 1f, lower panels), comparable to the frequency of observed hemizygous or homozygous loss. The gene discussed is PPP2R2A; the disease is prostate neoplasm.